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ABSTRACT
Motivation: Synthetic biology studies how to design and construct
biological systems with functions that do not exist in nature.
Biochemical networks, although easier to control, have been used
less frequently than genetic networks as a base to build a synthetic
system. To date, no clear engineering principles exist to design such
cell-free biochemical networks.
Results: We describe a methodology for the construction of
synthetic biochemical networks based on three main steps: design,
simulation and experimental validation. We developed BioNetCAD
to help users to go through these steps. BioNetCAD allows
designing abstract networks that can be implemented thanks
to CompuBioTicDB, a database of parts for synthetic biology.
BioNetCAD enables also simulations with the HSim software and
the classical Ordinary Differential Equations (ODE). We demonstrate
with a case study that BioNetCAD can rationalize and reduce further
experimental validation during the construction of a biochemical
network.
Availability and implementation: BioNetCAD is freely available at
http://www.sysdiag.cnrs.fr/BioNetCAD. It is implemented in Java and
supported on MS Windows. CompuBioTicDB is freely accessible at
http://compubiotic.sysdiag.cnrs.fr/
Contact: stephanie.rialle@sysdiag.cnrs.fr; franck.molina@sysdiag
.cnrs.fr
Supplementary information: Supplementary data are available at
Bioinformatics online.
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July 06, 2010
1 INTRODUCTION
Synthetic biology focuses on designing biological systems that are
characterized by non-natural functions and wide-ranging domains
of application: from bio-compatible devices (Elowitz and Leibler
2000; Gardner et al., 2000), biofuels (Dellomonaco et al. 2010;
Marner, 2009), drugs production (Ro et al., 2006), creation of smart
therapeutic systems (Lu and Collins 2009), to genetically modiﬁed
organismsforenvironmentalpurposes(CasesanddeLorenzo2005).
To this aim engineering principles (i.e. a rigorous methodology that
includes several key steps such as speciﬁcations, design, modeling,
∗To whom correspondence should be addressed.
fabrication and quality control) (Endy, 2005; Gulati et al., 2009)
are commonly used. A pioneer example is the BioBricks project
which focuses on the design and construction of genetic circuits
and on their expression in host cells to produce a useful behavior
or compound. To help in this long term goal, the registry of
standardbiologicalpartswasinitiatedbytheMassachusettsInstitute
of Technology (http://partsregistry.org/ Main_Page) in order to
conceptualize, standardize, organize in a hierarchy and register
compatible DNA parts. Another exciting approach is the use of
biological parts, such as enzymes and metabolites, as signals and
compounds to reproduce logic operations like those performed by
electronic circuits (Arkin and Ross, 1994; Baron et al., 2006; Strack
et al., 2008).
Given the complex nature of the biological material, most of
the engineering principles have not been exploited as yet for
the construction of artiﬁcial biological systems. Moreover, all the
current achievements are ‘hand-made’ approaches that are difﬁcult
to generalize. The clear necessity to develop concepts, methods
and technologies to support synthetic biology projects has been
emphasized repeatedly (Andrianantoandro et al., 2006; Endy, 2005)
and particularly the lack of computer-aided design (CAD) tools
that could facilitate the conceptualization, design and simulation
of such synthetic systems (Gulati et al., 2009). Ideally, CAD tools
should be linked to registries of standardized, modular and re-usable
biological parts, since well-deﬁned independent parts will ease the
efﬁcient development of synthetic biological systems (Arkin, 2008;
Peccoud et al., 2008). Several computational tools that speciﬁcally
support the design of artiﬁcial gene circuits are currently available
(Marchisio and Stelling, 2009). For instance, BioJADE (Goler et al.,
2008) is a graphical design tool to engineer genetic systems by
graphical representation of abstract components (like promoters,
ribosome binding sites, coding sequences, etc.). GenoCAD (Cai
et al., 2010) is a genetic design web tool based on context-free
grammar and a library of genetic parts which allows the design
of an easily downloadable DNA sequence. TinkerCell (Chandran
et al., 2009; http://www.tinkercell.com) is a synthetic biology CAD
tool for visually constructing and analyzing biological networks.
It allows the design and the simulation of biological networks from
a hierarchy of parts and modules that can be deﬁned by the user.
Most of the currently available CAD applications for synthetic
biology aim to develop genetic networks to be implemented in
modiﬁed microorganisms. However, the use of host cells produces
noise and not controllable behaviors, leading to poorly robust
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systems. Furthermore, the use of genetic networks implies ethical
questions that concern their use for in vivo tests. Consequently,
alternative, simpliﬁed protein/metabolic networks have been
proposed to tackle such difﬁculties (Bromley et al., 2008; Hold
and Panke, 2009). This kind of network is mainly composed of
sets of proteins performing related binding or catalytic activities
and transforming metabolite compounds. They do not rely on any
transcription or translation of genes, and therefore do not need any
host cell. If needed, they can be encapsulated into artiﬁcial vesicles
(Doktycz and Simpson 2007).
In this article, we describe a methodology to build protein-
based synthetic networks in three steps: design, simulation and
experimental validation. In order to assist the design and dynamic
simulation of such synthetic networks, we developed BioNetCAD,
an original bioinformatics tool coupled to CompuBioTicDB, a
database of biological components. The aim was to facilitate the
design of conceptual biochemical networks and to help the user in
ﬁnding the most suitable molecules to achieve successful circuits
that can be tested in a real biological environment. We illustrate
BioNetCAD use with a case study leading to the construction of a
network carrying a logical behavior.
2 METHODOLOGY FOR THE RATIONAL DESIGN
AND IMPLEMENTATION OF SYNTHETIC
SYSTEMS
Here we describe a three-step methodology for de novo design of
biological systems that includes both conceptual and experimental
aspectsinordertobuildreliablebiochemicalnetworks.Theﬁrsttwo
steps (i.e. design and simulation) are carried out in silico, while the
last one is the laboratory-based, experimental validation (Fig. 1).
2.1 Design
We propose to start this step by the construction of an abstract
network, i.e. a biochemical network made of theoretical molecules,
which will be implemented with well-characterized components.
Consequently, the identiﬁcation, formalization and storage of basic
componentsarekeyrequirementsofthisstepinviewofthenecessity
of predicting and controlling the behavior of the designed system.
The precise functionality of the individual components must be
described, i.e. how they act, in which conditions, their interactions,
etc. As a consequence, this work beneﬁtted of the previously
developed Bio  language (Maziere et al., 2004; Peres et al.,
2010), which allows a multi-scale formal description of biological
processes. Accordingly, the design of an abstract biological system
is the result of the combination of basic components that carry
elementary actions. We then pooled the identiﬁed components
and their description in a database, CompuBioTicDB, in order
to facilitate the construction of predictable and dependably
controllable, robust networks. Its concept is similar to that of the
BioBricks registry, but it aims to provide parts and devices useful
to the construction of non-living protein-based synthetic systems
rather than genetic-based systems.
2.2 Simulation
Simulation allows saving time and money by testing the consistency
of the designed system, certifying its robustness and predicting and
optimizing parameters, before the experimental validation assays.
Fig. 1. BioNetCAD allows the integration of CellDesigner,
CompuBioTicDB and simulation tools. An abstract network is designed
with CellDesigner according to the requirements speciﬁed by the user.
Through BioNetCAD, the CompuBioTicDB database is interrogated to
identify candidate molecules to implement the network. BioNetCAD returns
an implemented network that can be used for dynamical simulations by the
HSim software or the classical ODE tools linked with CellDesigner thanks
to the SBML format. Finally, the network can be experimentally validated.
The global behavior of the designed system is simulated with the
HSimsoftware(Amaretal.,2008).Thisstochasticautomatonallows
multi-agent type of simulations that admit dynamical (temporal
and spatial) analyses of the system and also tolerates very small
concentrations of molecules.
2.3 Experimental validation
The ﬁnal step is the experimental validation of the network: its
biochemical stability and behavior are checked to verify that it
accomplishes the expected task(s). Further optimization procedures
can be conducted. Because of the heaviness of the experimental
step (in regards to ﬁnancial costs and time) we should beneﬁciate
of the simulation to guide optimization process (initial quantities,
dynamics, etc.). In turn, the experimental data can be used to reﬁne
the modeling and simulation parameters.
3 BIONETCAD: A SYNTHETIC BIOLOGICAL
NETWORK COMPUTER-ASSISTED DESIGN
TOOL
Our synthetic network methodology requires computational tools
for assisting the user through its three steps. To accomplish this
requirement, we developed BioNetCAD, a plug-in for CellDesigner,
thatintegrates(i)thegraphicalfunctionalities(Kitanoetal.,2005)of
CellDesigner (Funahashi et al., 2003, 2008); (ii) CompuBioTicDB,
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Fig. 2. Step-wise network design/implementation and simulation using BioNetCAD. The design strategy starts with an abstract network designed according
to the user’s requirements and its representation in CellDesigner. Once the plug-in is launched, the user is asked to select a molecule within the network.
Then, several steps lead the user to specify different constraints about the selected molecule and the neighboring molecules in the network. For instance, if
the user selects a protein that catalyzes a reaction, he will be able to specify the enzymatic class (EC number), the substrate(s) and the product(s) of such
reaction. Next, BioNetCAD integrates the speciﬁcations and elaborates a SQL query on CompuBioTicDB to ﬁnd molecules that suit these requirements. The
results are displayed and the user can choose a molecule to implement the abstract molecule. The network is then updated with the chosen molecule and
possibly with linked molecules, such as substrate(s) or product(s). The user can then start again from another theoretical molecule in the network, and so on
until a fully implemented network is obtained. The HSim launcher functionality of BioNetCAD allows the automatic generation of HSim input ﬁles from the
CellDesigner model as deﬁned by the user and also launches the HSim software.
a database of biological elements; and (iii) simulation functions like
the HSim software and classical Ordinary Differential Equations
(ODEs). BioNetCAD assists the network design by iteratively
matching the basic components of the abstract network with
CompuBioTicDB components. Moreover, it can launch a simulation
of the network, using HSim or the simulation platforms which are
already integrated in CellDesigner (Fig. 1).
3.1 BioNetCAD for stepwise network design
Whendesigninganabstractnetwork,theuserhastoidentifyexisting
molecules that can perform the desired functionalities. For instance,
which molecules can he choose to build a small biochemical (e.g.
enzymatic) network that performs a given logic task? To help
answering this question, BioNetCAD facilitates the selection of
molecules to implement a protein network, in a stepwise manner
(Fig. 2 and Section 2 of Supplementary Material for the algorithm).
First, the user designs an abstract network according to speciﬁc
requirements and draws it using CellDesigner (Fig. 2A). At this
level, the user can already check the qualitative behavior of this
abstract network by launching qualitative simulations (Fig. 2B).
Next, the user selects a starting molecule (Fig. 2C) and speciﬁes the
constraints concerning that molecule (Fig. 2D) and its surrounding
molecular network (Fig. 2E). Based on these speciﬁcations,
BioNetCAD elaborates a query and executes it on CompuBioTicDB
in order to ﬁnd suitable molecular implementations for the selected
molecule and its surrounding network (Fig. 2F). BioNetCAD
presents the different results provided by the database and the
user can choose one of them (Fig. 2G) to build an intermediate
implemented network (Fig. 2H).This cycle is then repeated (Fig. 2I)
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until a fully implemented network is obtained (Fig. 2J), ready to be
simulated (Fig. 2K) and tested experimentally. Section 4 illustrates
the use of BioNetCAD with an example.
The adoption of CellDesigner as plug-in relies on the decision
to represent graphically biological systems using standardized
notations. Indeed, engineering methodology needs to be based on
standardnotationsandrepresentations;moreover,itseemsimportant
to start using tools that permit the exchange of information between
different models. Accordingly, CellDesigner supports the SBML
format (Hucka et al., 2003), which is widely used in the systems
biology community, to share networks models.
3.2 CompuBioTicDB for the choice and
implementation of molecules
3.2.1 Parts and devices The CompuBioTicDB database stores
two categories of components: biological molecules, such as
proteins and metabolites, and devices such as sensors, switches
or timekeepers, which use the biological molecules as basic
parts. Following the analogy with the electronic components,
we propose devices that can be assembled in order to form a
syntheticbiochemicalsystem.Thesedevicesaremolecularelements
which play pre-determined well-deﬁned roles, and are named
by the role they play. An example of device is the switch:
it can for instance switch on a synthetic biological system by
initiating a reaction that produces a compound indispensable for
the next reaction. Basically, those components are abstract, but their
molecular implementations are real proteins and small molecules
thatarecategorizedinCompuBioTicDB.Devicesconstituteahigher
level in the abstraction hierarchy of components for synthetic
biology in comparison to basic biological molecules. We classiﬁed
these functional devices in six categories: compartmentalization,
compartmental environment control, time management, shape
management, energy provider and biological signal management
devices.
3.2.2 BioNetCAD molecule implementation using
CompuBioTicDB CompuBioTicDB stores essentially proteins,
in particular enzymes and small molecules, such as substrates
or cofactors. CompuBioTicDB does not intend to create a
new database with information already contained in other
databases such as UniProtKB (The UniProt Consortium, 2010)
(http://www.uniprot.org/) or Brenda enzymes (Chang et al., 2009)
(http://www.brenda-enzymes.org/), but only to integrate structural,
functional and kinetics data that are needed when designing a
syntheticnetwork.Additionally,wehavedeﬁnedasyntheticbiology
score for proteins according to their easy of use in a synthetic
biology context. This score reﬂects the robustness of a protein,
i.e. its suitability for non-natural environments, also the potential
interactions with other proteins and environmental factors, such
as pH, temperature, ionic conditions, etc. This score is arbitrarily
given and is deﬁned as a scale of integers from 0 to 4:1 means
that a protein is not easily usable in a synthetic biology system,
while 4 indicates that it is a very good component for synthetic
systems. For instance, widely used enzymes in the biotechnology
ﬁeld are considered good candidates for synthetic biology, since
their robustness has been demonstrated by their use in various
conditions. Consequently, they received by default a score of 3.
Finally, 0 means that we do not know yet if the protein can be
easily handled or not, and that experiments need to be performed
to ascertain it.
3.3 BioNetCAD for the simulation of the dynamic
network behavior using the HSim launcher
The second main functionality of BioNetCAD is to make a link
between the network drawn with CellDesigner and the spatial and
temporal simulation that can be performed using the stochastic
automaton HSim (Amar et al., 2008). Based on the CellDesigner
network and parameters deﬁned by the user, the HSim input
conﬁguration ﬁle is constructed automatically by BioNetCAD and
the simulation can be launched. As shown in the next section,
HSim allowed us to verify that the designed network could perform
the expected tasks and helped in the choice/optimization of the
experimental parameters.
4 A CASE STUDY: IN SILICO NETWORK DESIGN,
SIMULATION AND IN VITRO EXPERIMENTAL
ASSAY
The general objective was to design a network that performs the
task of a molecular logic AND gate. The design of molecular
bio-logic gates is of great interest since it may be useful to feed
CompuBioTicDB with sophisticated components that could be
reused in synthetic networks and under different conditions.
4.1 Design
4.1.1 Requirements and generation of an abstract network First,
the BioNetCAD user had to deﬁne precisely the requirements. In
this case, the objective was to build a multi-enzymatic biochemical
‘AND’ gate, made of three enzymes, in which two input substrates
are transformed into one detectable product (one substrate being
processed by one enzyme, the other by another enzyme). Such
a multi-enzymatic AND gate opens various possibilities for
different reaction branching thanks to its multiple input metabolites.
Speciﬁcally, the requirements were deﬁned as follows:
• A serial network of three enzymes: the product of the ﬁrst one
was the substrate of the second one and so on.
• Two inputs. By ‘input’ we meant a substrate the initial
concentration of which was tunable.
• One input was the substrate of the ﬁrst enzyme in the network,
while the other was the substrate of the third enzyme.
• One output, which was a measurable product.
• The generation of the output was conditioned by the initial
presenceofthetwosubstrates(Fig.3B)followinginourcasean
ANDtruthtableasclassicallyexpressedinelectronics(Fig.3A,
right panel).
4.1.2 Generation of implemented networks using BioNetCAD
Starting from an abstract network drawn with CellDesigner, the
user employed BioNetCAD to obtain an implemented network with
realmolecules.A‘retro-implementation’approachwasfollowed,i.e.
the implementation started from the end (output) of the network.
First, the output molecule was selected with the constraint of
being a detectable product, in our case by a colorimetric assay.
Based on the results of the CompuBioTicDB search, BioNetCAD
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Fig. 3. Case study: design of a logicAND gate. (A) LogicAND gate, scheme and expected behavior. Inputs and outputs are implemented with small molecules
and the process is carried out by enzymatic reactions. (B)Abstract network of a multi-enzymaticAND gate with three enzymes. The abstract network is drawn
in accordance to the following requirements: serial network of three enzymes, the product of the ﬁrst one is the substrate of the second and so on, two inputs
which are tunable small molecules, one input is the substrate of the ﬁrst enzyme in the network, while the other is the substrate of the third enzyme, one
output which is a measurable product, production of the output conditioned by the initial presence of the two substrates. (C) Two examples of implementation
of a tri-enzyme AND gate. According to the choices made at each step of the BioNetCAD search on CompuBioTicDB, the same abstract network can lead to
different molecular implementations that fulﬁll the initial requirements. In the case study, the left network was chosen; thus, after implementation, input 1 of
the logic gate was represented by lactose, input 2 by ABTS and the output by oxidized ABTS.
proposed several molecules, such as oxidized ABTS or oxidized
o-Dianisidine, which are products of reactions catalyzed by
peroxidase, or nitrophenol, the product of the reaction catalyzed
by alkaline phosphatase. By making a choice (in this case oxidized
ABTS) the user created constraints on the upstream components
of the network. This choice implied peroxidase as implementation
of ‘enzyme 3’, ABTS as implementation of ‘input 2’ and H2O2 as
implementation of ‘interm2’. The H2O molecule was automatically
added into the network since it is a second product of the peroxidase
reaction. In the next step, ‘enzyme 2’ was selected, and the user
speciﬁed that it needed to give H2O2 as product. Again, several
moleculeswerefoundbyCompuBioTicDBandproposedtotheuser.
The user chose glucose oxidase, which uses glucose as substrate
(implementation of ‘interm1’). Using the same method, the ﬁrst
enzyme (β-galactosidase) was then selected among the proposed
molecules with lactose as substrate. Finally, a fully implemented
network was obtained (Fig. 3C, left scheme). Several alternative
implementations exist for a given abstract network depending on
the choices made by the user at each step of the search with
BioNetCAD in CompuBioTicDB. Thus, several networks can be
simulated and possibly assayed experimentally to be validated.
Figure 3C illustrates how a unique abstract network with speciﬁed
characteristics can lead to two different implemented networks that
share the same functionalities.
4.2 Modeling, simulation and experimental validation
Two modeling methods were chosen to simulate the behavior
of the designed multi-enzymatic logic AND gate network: ODE
continuous approach and HSim discrete approach. Both HSim
(Fig. 4A, upper panel) and ODE (Supplementary Fig. S1)
simulations conﬁrmed that the designed network behaved as a logic
AND gate according to the expected AND truth table with lactose
and ABTS as inputs. As expected, output production (oxidized
ABTS=1) was only observed when both inputs (lactose=1 and
ABTS=1) were initially present.
To more precisely characterize the behavior and to study the
global velocity of the network, different simulations were made
using various concentrations of the three enzymes. HSim and ODE
simulations gave comparable curves (Fig. 4A, lower panel and
Supplementary Fig. S1). In order to optimize the concentration
of the three enzymes and to reduce the time needed and the
amount of material used during the experimental validation, a
series of enzyme ratios were simulated. Test e, with a 3:3:3
ratio (U/mL; β-galactosidase, glucose oxidase and peroxidase,
respectively), showed the highest rate of output formation, as
expected, but required high enzyme concentrations. Conversely, test
b (3:1.6:0.04), even with two times less glucose oxidase and 75
times less peroxidase than test e, still presented a satisfactory output
formation.Curvesa(3:0.4:0.04),c(0.75:1.6:0.04)andd(1:1:1)
were almost superimposed in both simulations. We veriﬁed in all
simulations that substrates/inputs (lactose and ABTS) were not in
limiting concentrations (Supplementary Material). The simulations
show that the test b was the most satisfactory for output formation
and low-enzymes concentration requirements compared to other
tests.
The experimental validation, with the different input
conﬁgurations (Fig. 4B. top-left) measured using the conditions
of test b after 30min, gave a AND gate output signal (see
Supplementary Material for information about materials and
methods). The cut off value of the AND gate was established for
output 0 as absorbance <0.08 and for output 1 as absorbance >0.16.
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Fig. 4. Case study: simulation and experimental validation of a logic AND
gate. Production of oxidized ABTS (output) in the course of time (minutes)
was assessed by HSim simulation (A) and biochemical assays (B), with
the same initial concentrations of inputs (250mM of lactose and 2.5mM
of ABTS) and different enzyme concentration ratios. For both graphics,
concentrations of enzymes are: a=3, 0.4 and 0.04; b=3, 1.6 and 0.04;
c=0.75, 1.6 and 0.04; d=1, 1 and 1; e=3, 3 and 3U/mL (β-galactosidase,
glucose oxidase and peroxidase, respectively). Bar representation of the
AND gate (condition b) output after 30min of simulation/experimentation
is showed in the top left panel of each graphic.
The experimental curves (Fig. 4B, lower panel) were in line with
the results obtained during the simulations: assays e and b presented
elevated rates of output formation, while assays c, d and a showed
lower rates. On the other hand, the experimental validation
gave a better resolution than the simulations for curves a, c, d.
Unfortunately, after 60 min, curve e exceeds the maximum limit of
the spectrophotometer (OD=3).
Altogether, this demonstrates that the characterization of small
networks using simulation is relevant for rationalizing the choice
of experimental conditions used to validate a synthetic biochemical
network.
5 CONCLUSION AND DISCUSSION
Although many synthetic biology projects aim to build genetic
networks within living cells, only few recent works focused on the
design of cell-free biochemical (signaling or metabolic) networks.
In this case, the synthetic system is not self-replicable but its
composition and behavior might be better controlled. This may be
of great advantage for eventual future use for health applications.
Recently, Grunberg et al. (2010) proposed a framework for the
design of synthetic protein networks using interactions between
modularproteins.HowevertheystillbasedtheirworkonDNAparts.
Other studies aimed at rewiring signaling circuits (Pryciak 2009;
Zeke et al., 2009) by taking advantage of the amazing modularity
of protein domains to produce fusion proteins in order to create
non-natural interactions and thus modify existing pathways.
Here we propose to use engineering principles to design-
controlled biochemical synthetic networks.To support our approach
we developed a methodology based on three main steps (i.e. design,
simulation and experimental validation) which can be easily carried
out using the computing tool BioNetCAD.
In the design step, it is necessary to use BioNetCAD, integrated
in the CellDesigner environment, to draw an abstract network
using SBGN annotation standards. To efﬁciently implement the
abstract network of interest we propose a retro-implementation
method using BioNetCAD in combination with CompuBioTicDB.
CompuBioTicDB is central during our design process because it
assembles information on abstract functions, associated constraints
and kinetic parameters in order to build an implemented network
that satisﬁes the constraints of the network structure and of
the contextual dependencies of the well-studied molecules found
in CompuBioTicDB. To improve our design/implementation
methodology it would be of great interest to have a multi-scale
vision of the de novo design of protein networks (from protein
domains to system levels) and thus to include non-natural well-
characterized proteins as CompuBioTicDB parts. To this aim, we
currently work on the integration in CompuBioTicDB of the recent
conceptofelementarybricksofactionatthelevelofproteindomains
(Maziere et al., 2004; Peres et al., 2010).
Qualitative simulations can then be used during the design
step to anticipate the global behavior of the abstract network.
This can be done before any speciﬁc molecular implementation.
Finally, before going into costly experimental validation, different
kinds of quantitative in silico simulations can be performed to
check the stability of the global network behavior and to optimize
various parameters (quantities, kinetics, etc.). Currently, the kinetic
parameters appear to be a limiting factor since they are not often
available, or not relevant or contradictory. A simple example of
design of a multi-enzymaticAND logic gate allowed demonstrating
the robustness of our methodology which was also conﬁrmed by
experimental tests under various conditions.
Compared to TinkerCell (the only currently available CAD tool
able of designing non genetic networks), BioNetCAD focuses
on protein networks using current graphical and model exchange
standards (see Supplementary Material). In addition, it integrates
originaltoolsasCompuBioTicDBandthespatio-temporalsimulator
HSim.
Inconclusion,BioNetCADconstitutesacomputerassisteddesign
tool that greatly enhances the rational design and optimization
of synthetic biological system. It can be used for various
purposes ranging from bioassay design, system design or eventually
modiﬁcation of existing networks.
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